9007 ORAL Phase II Study of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker, in Patients With EGFR FISH-positive Advanced NSCLC

✍ Scribed by Finocchiaro, G.; Santoro, A.; Grossi, F.; Bidoli, P.; Favaretto, A.; Clementi, L.; Massey, D.; Lorence, R.; Cappuzzo, F.

• Book ID: 122795489
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 59 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72319-X